Cargando…
Response to “Reassessing the death risk related to probiotics in critically ill patients”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330025/ https://www.ncbi.nlm.nih.gov/pubmed/28241845 http://dx.doi.org/10.1186/s13054-017-1618-0 |
| _version_ | 1782511177164652544 |
|---|---|
| author | Manzanares, William Wischmeyer, Paul E. |
| author_facet | Manzanares, William Wischmeyer, Paul E. |
| author_sort | Manzanares, William |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5330025 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53300252017-03-03 Response to “Reassessing the death risk related to probiotics in critically ill patients” Manzanares, William Wischmeyer, Paul E. Crit Care Letter BioMed Central 2017-02-27 /pmc/articles/PMC5330025/ /pubmed/28241845 http://dx.doi.org/10.1186/s13054-017-1618-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter Manzanares, William Wischmeyer, Paul E. Response to “Reassessing the death risk related to probiotics in critically ill patients” |
| title | Response to “Reassessing the death risk related to probiotics in critically ill patients” |
| title_full | Response to “Reassessing the death risk related to probiotics in critically ill patients” |
| title_fullStr | Response to “Reassessing the death risk related to probiotics in critically ill patients” |
| title_full_unstemmed | Response to “Reassessing the death risk related to probiotics in critically ill patients” |
| title_short | Response to “Reassessing the death risk related to probiotics in critically ill patients” |
| title_sort | response to “reassessing the death risk related to probiotics in critically ill patients” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330025/ https://www.ncbi.nlm.nih.gov/pubmed/28241845 http://dx.doi.org/10.1186/s13054-017-1618-0 |
| work_keys_str_mv | AT manzanareswilliam responsetoreassessingthedeathriskrelatedtoprobioticsincriticallyillpatients AT wischmeyerpaule responsetoreassessingthedeathriskrelatedtoprobioticsincriticallyillpatients |